Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Alpha1-Antitrypsin Deficiency

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States

    Contact: Study coordinator (Site Contact) · 602-274-7195
    Contact: Principal Investigator (Justin Reynolds)
  • Mayo Clinic - PPDS, Phoenix, Arizona, United States

    Contact: Study coordinator (Site Contact) · vargas.hugo@mayo.edu · 480-301-6990
    Contact: Principal Investigator (Hugo Vargas)
  • University of Arizona Thomas D. Boyer Liver Institute, Tucson, Arizona, United States

    Contact: Study coordinator (Site Contact) · gdblock@deptofmed.arizona.edu · 520-626-3005
    Contact: Principal Investigator (Geoffrey Block)
  • University of California San Diego, La Jolla, California, United States

    Contact: Study coordinator (Site Contact) · roloomba@health.ucsd.edu · 858-534-2555
    Contact: Principal Investigator (Rohit Loomba)
  • UCLA Pulmonary and Critical Care, Los Angeles, California, United States

    Contact: Study coordinator (Site Contact) · 310-825-8061
    Contact: Principal Investigator (Igor Barjaktarevic)
  • University of California Benioff Children's Hospital, San Francisco, California, United States

    Contact: Study coordinator (Site Contact) · PROSENTH@ucsf.edu · 415-476-5892
    Contact: Principal Investigator (Philip Rosenthal)
  • Peak Gastroenterology Associates, Colorado Springs, Colorado, United States

    Contact: Study coordinator (Site Contact) · 719-636-1201
    Contact: Principal Investigator (Bhaktasharan Patel)
  • Schiff Center for Liver Diseases/University of Miami, Miami, Florida, United States

    Contact: Study coordinator (Site Contact) · idsresearch@med.miami.edu · 305-243-5185
    Contact: Principal Investigator (Eugene Schiff)
  • Indiana University School of Medicine-Indianapolis, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Contact) · 317-278-4607
    Contact: Principal Investigator (Raj Vuppalanchi)
  • University Of Iowa Hospitals And Clinics, Iowa City, Iowa, United States

    Contact: Study coordinator (Site Contact) · Tomohiro-tanaka@uiowa.edu · 319-356-2577
    Contact: Principal Investigator (Tomohiro Tanaka)
  • Boston Medical Center, Boston, Massachusetts, United States

    Contact: Study coordinator (Site Contact) · arpan.mohanty@bmc.org · 617-638-6525
    Contact: Principal Investigator (Arpan Mohanty)
  • University of Michigan Hospital - 1500 E Medical Center Dr, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Contact) · 734-232-3741
    Contact: Principal Investigator (Robert Fontana)
  • Henry Ford Health System, Novi, Michigan, United States

    Contact: Study coordinator (Site Contact) · sgordon3@hfhs.org · 248-344-6688
    Contact: Principal Investigator (Stuart Gordon)
  • Mayo Clinic PPDS, Rochester, Minnesota, United States

    Contact: Study coordinator (Site Contact) · 507-284-0141
    Contact: Principal Investigator (Harmeet Malhi)
  • NYU Langone Medical Center, New York, New York, United States

    Contact: Study coordinator (Site Contact) · viviana.figueroadiaz@nyumc.org · 212-263-3643
    Contact: Principal Investigator (Viviana Figueroa Diaz)
  • Columbia University Irving Medical Center, New York, New York, United States

    Contact: Principal Investigator (Monica Goldklang)
  • University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Contact) · 216-983-0879
    Contact: Principal Investigator (Seth Sclair)
  • Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States

    Contact: Study coordinator (Site Contact) · tcraig@pennstatehealth.psu.edu · 717-531-7532
    Contact: Principal Investigator (Timothy Craig)
  • Texas Liver Institute American Research Corporation, San Antonio, Texas, United States

    Contact: Study coordinator (Site Contact) · lawitz@txliver.com · 210-253-3426
    Contact: Principal Investigator (Eric Lawitz)
  • Bon Secours St. Mary's Hospital, Newport, Virginia, United States

    Contact: Study coordinator (Site Contact) · mitchell_shiffman@bshsi.org · 804-977-8920
    Contact: Principal Investigator (Mitchell Schiffman)
  • LKH-Universitätsklinikum Graz, Graz, Austria

    Contact: Study coordinator (Site Contact) · martin.wagner@medunigraz.at · +4331638580287
    Contact: Principal Investigator (Martin Wagner)
  • KABEG - Klinikum Klagenfurt Am Wörthersee, Klagenfurt, Austria

    Contact: Principal Investigator (Markus Peck-Radosavljevic)
  • UZ Antwerpen, Antwerp, Belgium

    Contact: Study coordinator (Site Contact) · sven.francque@uza.be · +3238213323
    Contact: Principal Investigator (Sven Francque)
  • UZ Leuven, Leuven, Belgium

    Contact: Study coordinator (Site Contact) · jef.verbeek@uzleuven.be · +328888888888
    Contact: Principal Investigator (Jef Verbeek)
  • Inspiration Research Limited, Toronto, Ontario, Canada

    Contact: Study coordinator (Site Contact) · (416) 944-9602
    Contact: Principal Investigator (Kenneth Chapman)
  • Hôpital de La Croix Rousse, Lyon, France

    Contact: Study coordinator (Site contact) · teresa.antonini@aphp.fr · +33145596790
    Contact: Principal Investigator (Teresa Antonini)
  • Hopital PONTCHAILLOU CHU de Rennes, Rennes, France

    Contact: Study coordinator (Site Contact) · edouard.bardou-jacquet@chu-rennes.fr · +33299284297
    Contact: Principal Investigator (Edouard Bardou-Jacquet)
  • Hôpital Paul Brousse, Val-de-Marne, France

    Contact: Study coordinator (Site Contact) · audrey.coilly@aphp.fr · +33145593336
    Contact: Principal Investigator (Audrey Coilly)
  • Universitätsklinikum der RWTH Aachen, Aachen, Germany

    Study coordinator · pstrnad@ukaachen.de · +492418035324
    Contact: Principal Investigator (Pavel Strnad)
  • Charité - Campus Virchow-Klinikum, Berlin, Germany

    Contact: Study coordinator (Site Contact) · frank.tacke@charite.de · +4939450553022
    Contact: Principal Investigator (Frank Tacke)
  • Hannover Medical School, Hanover, Germany

    Contact: Study coordinator (Site Contact) · +495115322730
    Contact: Principal Investigator (Heiner Wedemeyer)
  • Universitätsklinikum Tübingen, Tübingen, Germany

    Contact: Study coordinator (Site Contact) · +4970712977661
    Contact: Principal Investigator (Christoph Berg)
  • Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

    Contact: Study coordinator (Site Contact) · +390382503777
    Contact: Principal Investigator (Angelo Corsico)
  • ID Clinic Arkadiusz Pisula, Mysłowice, Poland

  • CCA Hospital Braga, Braga, Portugal

    Contact: Principal Investigator (Carla Rolanda)
  • Hospital Dr. Nélio Mendonça, Funchal, Portugal

    Contact: Study coordinator (Site Contact) · (351) 291-7056 x00
    Contact: Principal Investigator (Vitor Pereira)
  • Centro Hospitalar de Universitário de Santo António E.P.E, Porto, Portugal

    Contact: Study coordinator (Site Contact) · +351918000000
    Contact: Principal Investigator (Luís Maia)
  • Hospital Universitario Virgen del Rocio - PPDS, Seville, Spain

    Contact: Study coordinator (Site Contact) · mromerogomez@us.es · +34955012065
    Contact: Principal Investigator (Manuel Romero Gómez)
  • Karolinska Universitetssjukhuset Huddinge, Huddinge, Sweden

    Contact: Study coordinator (Site Contact) · +46858580000
    Contact: Principal Investigator (Staffan Wahlin)
  • Universitätsspital Bern, Bern, Switzerland

    Contact: Study coordinator (Site Contact) · +41442663568
    Contact: Principal Investigator (Guido Stirnimann)
  • King's College Hospital, London, United Kingdom

    Contact: Study coordinator (Site Contact) · +442032993506
    Contact: Principal Investigator (Aftab Ala)
מובילי המחקר
  • Study Director

    Takeda